Developer docs
API playgroundTry for free, no card

Search company profiles

Noxilizer

Full company profile

uuid00004c2

Namestring
Noxilizer
Legal namestring
Noxilizer, Inc.
Websiteurl
noxilizer.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Noxilizer is a privately held medical technology company that has commercialized a proprietary nitrogen dioxide (NO2) gas sterilization process operating at ultra-low temperatures of 10°C to 30°C. The company sells the UltraNox RTS Sterilizer product line in chamber sizes ranging from 400 liters to 16,000 liters, with single- and double-door configurations, optional minimal vacuum cycles for pressure-sensitive products, and integrated NO2 scrubbing. Cycle times of 6-12 hours including rapid aeration (minutes versus days for competing methods) and a mechanism of lethality based on DNA degradation with no cellular repair pathway distinguish the technology from conventional ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), and peracetic acid modalities. Noxilizer has secured first-mover regulatory milestones: an FDA-approved combination product (October 2024) and a first EMA authorization (April 2025), both for biotech drugs in prefilled syringes.

The company's business model combines capital equipment sales, contract sterilization services, and recurring support. Direct enterprise sales target pharmaceutical, biotech, and medical device manufacturers for in-house equipment installation, supplemented by on-site contract sterilization at the Hanover, MD headquarters and European facilities. Distribution is extended through CMO partnerships (equipment installed in Europe, US, and Asia) and a Sterigenics channel partnership for broader service access. Ancillary revenue includes feasibility studies (45-60 days), pre-validation, full sterilization validation (3-5 months) following ISO 14937, regulatory and design consulting, and consumables/technical support. Customers include Regeneron (intravitreal therapies), Terumo (polymer prefilled syringes), and multiple unnamed European and global biotech companies working on ophthalmic drug-device combinations and platform-wide therapeutic delivery systems.

Noxilizer operates from Hanover, Maryland with 11-50 employees and is venture-backed, most recently by a $30 million growth capital round led by NewVale Capital in September 2025. Leadership includes CEO Christopher A. Thatcher (appointed May 2024, prior Neuronetics CEO and 2018 IPO), Executive Chairman Lawrence Bruder, SVP R&D David Opie, Ph.D., and a board with representation from NewVale Capital partners. The company is positioned in a contract sterilization market projected to reach $9.11 billion by 2030 at a 9.4% CAGR, with growth catalyzed by EtO capacity constraints and regulatory remediation mandates driving demand for alternative sterilization modalities.

Short descriptiontext

Noxilizer provides room-temperature nitrogen dioxide (NO2) sterilization technology and UltraNox equipment for pharmaceutical, biotech, and medical device manufacturers, offering capital equipment sales, contract sterilization services, and validation support globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHanover, United States
HQ citystring
Hanover
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nitrogen dioxide sterilization, sterilization equipment manufacturing, contract sterilization services, pharmaceutical sterilization validation, medical device sterilization
Industry3 codes
PRIMARYHLAHANAA
Sterilization Equipment & Systems (Autoclaves, Low-Temp, ETO, H2O2, UV)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAB
Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAC
Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Chemicals & Allied Products2800
  • Miscellaneous Chemical Products2890
Product category
Sterilization Equipment
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Sterilization Equipment Sales
TypeHardware Sales
Description

Sale of UltraNox RTS Sterilizers ranging from 400L to 16,000L chamber sizes. Customers purchase equipment for installation in their own facilities or at CMOs.

noxilizer.com
2Contract Sterilization Services
TypeManaged Services
Description

On-site contract sterilization at Hanover, MD facility and European locations. Provides terminal sterilization services for biopharmaceutical and medical device products.

noxilizer.com
3Feasibility and Validation Studies
TypeProfessional Services
Description

Sterilization testing services including feasibility studies (45-60 days), pre-validation studies, and full sterilization validation (3-5 months) following ISO 14937:2009.

noxilizer.com
4Regulatory and Design Consulting
TypeProfessional Services
Description

Consulting services for regulatory submissions, FDA pre-submission meeting requests, 510(k) process management, and drug-delivery system design for sterilization compatibility.

noxilizer.com
5Consumables and Support Services
TypeSubscription Recurring
Description

Customer and technical service, consumable product line, and ongoing support for installed equipment.

noxilizer.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1UltraNox Sterilizer Equipment
ModelOtherBilling cadenceMulti-year contract
Notes

Custom quotes based on chamber size requirements (400L to 16,000L), configuration (single/double door), and annual volume needs.

noxilizer.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Noxilizer sells proprietary ultra-low temperature (10°C–30°C) nitrogen dioxide (NO2) gas sterilization technology to pharmaceutical, biotech, and medical device manufacturers. The company manufactures and sells UltraNox RTS Sterilizers (400L to 16,000L chambers) and offers contract sterilization services, feasibility/validation studies, regulatory consulting, and ongoing consumables/support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Cycle times of 6-12 hours including aeration vs. 1-4 weeks at external contract sterilizers
+3 more records
Product and service3 records
1UltraNox RTS Sterilizers
CategorySterilization Equipment
2Contract Sterilization Services
CategorySterilization Services
3Feasibility and Validation Studies
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Contract sterilization services partnership providing additional capacity for NO2 sterilization services. Allows customers to access NO2 sterilization through Sterigenics facilities.

2Contract Manufacturing Organizations (CMOs)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CMOs install UltraNox NO2 Production Sterilizers to offer sterilization services. Equipment installed in Europe, US, and Asia. Expands geographic access and capacity for customers using CMO manufacturing model.

noxilizer.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest global sterilization services provider offering EtO, gamma, and E-beam sterilization. Direct competitor to Noxilizer's contract sterilization services and a current partner/distribution channel for Noxilizer's NO2 technology across Sterigenics' global facilities.

2STERIS
TypeBroad incumbent
Description

Major medical sterilization equipment manufacturer and contract sterilization services provider. Competes broadly with Noxilizer across sterilization modalities and is a dominant player in hospital and pharmaceutical sterilization markets.

TypeBroad incumbent
Description

Global medical technology company with significant sterilization equipment business including low-temperature sterilization systems. Competes with Noxilizer's UltraNox sterilizer product line for medical device and pharmaceutical manufacturers.

TypeDirect peer
Description

Italian manufacturer of sterilization equipment for pharmaceutical and medical device industries, including low-temperature systems. Direct competitor in pharmaceutical sterilization equipment market, especially in Europe.

TypeDirect peer
Description

Manufacturer of sterilization and disinfection equipment for medical, laboratory, and pharmaceutical applications. Competes with Noxilizer in medical device and laboratory sterilization equipment markets.

6Cosmed Group
TypeDirect peer
Description

Contract sterilization services provider offering EtO and gamma sterilization for medical device and pharmaceutical industries. Direct competitor to Noxilizer's contract sterilization services business.

TypeDirect peer
Description

Provider of contract electron beam (E-beam) sterilization services for medical devices, pharmaceuticals, and consumer products. Competes with Noxilizer in the alternative sterilization methods market.

TypeDirect peer
Description

Specializes in low-temperature sterilization equipment and contract sterilization services using proprietary methods. Most direct competitor to Noxilizer in alternative low-temperature sterilization for temperature-sensitive medical products.

TypeBroad incumbent
Description

Provider of bio-decontamination systems using vaporized hydrogen peroxide (VHP) technology. Competes with Noxilizer's NO2 technology in pharmaceutical and medical device sterilization applications, particularly for sensitive products.

TypeBroad incumbent
Description

Former independent provider of infection prevention and sterilization products for medical and dental markets. Acquired by STERIS, but historically competed with Noxilizer in medical sterilization and infection control segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Noxilizer

Sterilization Equipmentnoxilizer.com

Noxilizer provides room-temperature nitrogen dioxide (NO2) sterilization technology and UltraNox equipment for pharmaceutical, biotech, and medical device manufacturers, offering capital equipment sales, contract sterilization services, and validation support globally.

What Noxilizer does

Noxilizer is a privately held medical technology company that has commercialized a proprietary nitrogen dioxide (NO2) gas sterilization process operating at ultra-low temperatures of 10°C to 30°C. The company sells the UltraNox RTS Sterilizer product line in chamber sizes ranging from 400 liters to 16,000 liters, with single- and double-door configurations, optional minimal vacuum cycles for pressure-sensitive products, and integrated NO2 scrubbing. Cycle times of 6-12 hours including rapid aeration (minutes versus days for competing methods) and a mechanism of lethality based on DNA degradation with no cellular repair pathway distinguish the technology from conventional ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), and peracetic acid modalities. Noxilizer has secured first-mover regulatory milestones: an FDA-approved combination product (October 2024) and a first EMA authorization (April 2025), both for biotech drugs in prefilled syringes.

The company's business model combines capital equipment sales, contract sterilization services, and recurring support. Direct enterprise sales target pharmaceutical, biotech, and medical device manufacturers for in-house equipment installation, supplemented by on-site contract sterilization at the Hanover, MD headquarters and European facilities. Distribution is extended through CMO partnerships (equipment installed in Europe, US, and Asia) and a Sterigenics channel partnership for broader service access. Ancillary revenue includes feasibility studies (45-60 days), pre-validation, full sterilization validation (3-5 months) following ISO 14937, regulatory and design consulting, and consumables/technical support. Customers include Regeneron (intravitreal therapies), Terumo (polymer prefilled syringes), and multiple unnamed European and global biotech companies working on ophthalmic drug-device combinations and platform-wide therapeutic delivery systems.

Noxilizer operates from Hanover, Maryland with 11-50 employees and is venture-backed, most recently by a $30 million growth capital round led by NewVale Capital in September 2025. Leadership includes CEO Christopher A. Thatcher (appointed May 2024, prior Neuronetics CEO and 2018 IPO), Executive Chairman Lawrence Bruder, SVP R&D David Opie, Ph.D., and a board with representation from NewVale Capital partners. The company is positioned in a contract sterilization market projected to reach $9.11 billion by 2030 at a 9.4% CAGR, with growth catalyzed by EtO capacity constraints and regulatory remediation mandates driving demand for alternative sterilization modalities.

Noxilizer firmographics

Firmographics
Name
Noxilizer
Legal name
Noxilizer, Inc.
Website
https://noxilizer.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Noxilizer provides room-temperature nitrogen dioxide (NO2) sterilization technology and UltraNox equipment for pharmaceutical, biotech, and medical device manufacturers, offering capital equipment sales, contract sterilization services, and validation support globally.
Ownership category
akta.pro rank

Noxilizer industry classification

Industry
Product category
Sterilization Equipment
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Chemicals & Allied Products (2800), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYHLAHANAA
Sterilization Equipment & Systems (Autoclaves, Low-Temp, ETO, H2O2, UV)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAB
Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAC
Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables

Keywords

  • Nitrogen dioxide sterilization
  • Sterilization equipment manufacturing
  • Contract sterilization services
  • Pharmaceutical sterilization validation
  • Medical device sterilization

Where Noxilizer is headquartered

Location

Headquarters

HQ city
Hanover
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Noxilizer business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Sterilization Equipment Sales: Sale of UltraNox RTS Sterilizers ranging from 400L to 16,000L chamber sizes. Customers purchase equipment for installation in their own facilities or at CMOs.
  2. Contract Sterilization Services: On-site contract sterilization at Hanover, MD facility and European locations. Provides terminal sterilization services for biopharmaceutical and medical device products.
  3. Feasibility and Validation Studies: Sterilization testing services including feasibility studies (45-60 days), pre-validation studies, and full sterilization validation (3-5 months) following ISO 14937:2009.
  4. Regulatory and Design Consulting: Consulting services for regulatory submissions, FDA pre-submission meeting requests, 510(k) process management, and drug-delivery system design for sterilization compatibility.
  5. Consumables and Support Services: Customer and technical service, consumable product line, and ongoing support for installed equipment.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractUltraNox Sterilizer Equipment

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Noxilizer product offering

Product offering

Core offering

Noxilizer sells proprietary ultra-low temperature (10°C–30°C) nitrogen dioxide (NO2) gas sterilization technology to pharmaceutical, biotech, and medical device manufacturers. The company manufactures and sells UltraNox RTS Sterilizers (400L to 16,000L chambers) and offers contract sterilization services, feasibility/validation studies, regulatory consulting, and ongoing consumables/support.

Differentiator

Problem solved

Functional benefit

Products and services

  • UltraNox RTS Sterilizers
  • Contract Sterilization Services
  • Feasibility and Validation Studies

Quantifiable outcome

  • Cycle times of 6-12 hours including aeration vs. 1-4 weeks at external contract sterilizers
  • +3 more outcomes

Companies that use Noxilizer

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Noxilizer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Noxilizer partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • SterigenicscoreChannel Partner/ Reseller/ DistributorContract sterilization services partnership providing additional capacity for NO2 sterilization services. Allows customers to access NO2 sterilization through Sterigenics facilities.
  • Contract Manufacturing Organizations (CMOs)coreChannel Partner/ Reseller/ DistributorCMOs install UltraNox NO2 Production Sterilizers to offer sterilization services. Equipment installed in Europe, US, and Asia. Expands geographic access and capacity for customers using CMO manufacturing model.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Noxilizer competitors and assessment

Company assessment

Broad incumbents

  • Sterigenics (Sotera Health): Largest global sterilization services provider offering EtO, gamma, and E-beam sterilization. Direct competitor to Noxilizer's contract sterilization services and a current partner/distribution channel for Noxilizer's NO2 technology across Sterigenics' global facilities.
  • STERIS: Major medical sterilization equipment manufacturer and contract sterilization services provider. Competes broadly with Noxilizer across sterilization modalities and is a dominant player in hospital and pharmaceutical sterilization markets.
  • Getinge: Global medical technology company with significant sterilization equipment business including low-temperature sterilization systems. Competes with Noxilizer's UltraNox sterilizer product line for medical device and pharmaceutical manufacturers.
  • Bioquell (Ecolab): Provider of bio-decontamination systems using vaporized hydrogen peroxide (VHP) technology. Competes with Noxilizer's NO2 technology in pharmaceutical and medical device sterilization applications, particularly for sensitive products.
  • Cantel Medical (now part of STERIS): Former independent provider of infection prevention and sterilization products for medical and dental markets. Acquired by STERIS, but historically competed with Noxilizer in medical sterilization and infection control segments.

Direct peers

  • Fedegari Group: Italian manufacturer of sterilization equipment for pharmaceutical and medical device industries, including low-temperature systems. Direct competitor in pharmaceutical sterilization equipment market, especially in Europe.
  • Tuttnauer: Manufacturer of sterilization and disinfection equipment for medical, laboratory, and pharmaceutical applications. Competes with Noxilizer in medical device and laboratory sterilization equipment markets.
  • Cosmed Group: Contract sterilization services provider offering EtO and gamma sterilization for medical device and pharmaceutical industries. Direct competitor to Noxilizer's contract sterilization services business.
  • E-BEAM Services: Provider of contract electron beam (E-beam) sterilization services for medical devices, pharmaceuticals, and consumer products. Competes with Noxilizer in the alternative sterilization methods market.
  • Anderson Sterilizers (Steritec Products): Specializes in low-temperature sterilization equipment and contract sterilization services using proprietary methods. Most direct competitor to Noxilizer in alternative low-temperature sterilization for temperature-sensitive medical products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Noxilizer social profiles

Digital presence

Noxilizer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Noxilizer leadership team

Management profile

Number of profiles

Profiles7 records

Noxilizer funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Noxilizer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noxilizer

What does Noxilizer do?

Noxilizer sells proprietary ultra-low temperature (10°C–30°C) nitrogen dioxide (NO2) gas sterilization technology to pharmaceutical, biotech, and medical device manufacturers. The company manufactures and sells UltraNox RTS Sterilizers (400L to 16,000L chambers) and offers contract sterilization services, feasibility/validation studies, regulatory consulting, and ongoing consumables/support.

Is Noxilizer a public or private company?

Noxilizer is a private company. It is classified as venture growth investor backed and is currently operating.

When was Noxilizer founded?

Noxilizer was founded in 2012. It employs 51 to 100 people.

Where is Noxilizer based?

Noxilizer is headquartered in Hanover, United States, in the North America region.

How does Noxilizer make money?

Five revenue lines are on record. Sterilization Equipment Sales are the primary driver. The others are contract Sterilization Services, feasibility and Validation Studies, regulatory and Design Consulting and consumables and Support Services.

Who are Noxilizer's main competitors?

Broad incumbents on record are Sterigenics (Sotera Health), STERIS, Getinge, Bioquell (Ecolab) and Cantel Medical (now part of STERIS). Direct peers are Fedegari Group, Tuttnauer, Cosmed Group, E-BEAM Services and Anderson Sterilizers (Steritec Products).

Does Noxilizer have an API?

No public API is recorded for Noxilizer.

What industry is Noxilizer in?

Noxilizer's product category is Sterilization Equipment. Its primary akta.pro industry code is HLAHANAA, Sterilization Equipment & Systems (Autoclaves, Low-Temp, ETO, H2O2, UV), with a secondary code of HLAHANAB, Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers). Its NAICS code is 339113 and its SIC code is 2800.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magNoxilizer Expands Access to Nitrogen Dioxide Terminal Sterilization CapacityNoxilizer Inc. has secured $30 million in growth capital from NewVale Capital to expand its nitrogen dioxide sterilization platform. The company aims to meet increasing global demand by providing an alternative to ethylene oxide (EtO) sterilization, which faces capacity constraints and remediation mandates.GeneOnline NewsNoxilizer Secures $30 Million to Expand Nitrogen Dioxide Sterilization Technology for Healthcare ManufacturersNoxilizer, Inc. has secured $30 million in growth capital led by NewVale Capital to expand its nitrogen dioxide sterilization technology for healthcare manufacturers. The funding will be used to enhance infrastructure and accelerate the global adoption of this sustainable alternative to traditional sterilization methods.NoxilizerNoxilizer Expands Access to Commercial-Scale Nitrogen Dioxide Terminal Sterilization Capacity with $30 Million in Growth Capital Led by NewVale Capital -Noxilizer announced a $30 million growth capital financing led by NewVale Capital to expand its commercial-scale nitrogen dioxide sterilization capacity. The investment aims to address the urgent market demand for alternatives to ethylene oxide as manufacturers face increasing capacity constraints and regulatory mandates.PR NewswireNoxilizer Expands Access to Commercial-Scale Nitrogen Dioxide Terminal Sterilization Capacity with $30 Million in Growth Capital Led by NewVale CapitalNoxilizer announced a $30 million growth capital financing led by NewVale Capital to expand access to its nitrogen dioxide terminal sterilization platform. The company aims to meet growing global demand for alternatives to ethylene oxide, with the platform already validated and used by leading manufacturers.YahooNoxilizer Expands Access to Commercial-Scale Nitrogen Dioxide Terminal Sterilization Capacity with $30 Million in Growth Capital Led by NewVale CapitalNoxilizer announced a $30 million growth capital financing led by NewVale Capital to expand its nitrogen dioxide-based terminal sterilization capacity. The investment aims to meet increasing global demand for validated alternatives to ethylene oxide (EtO) among biopharmaceutical and medical device manufacturers. This expansion addresses capacity constraints and remediation mandates facing existing EtO providers.citybizNoxilizer Appoints Christopher A. Thatcher as CEONoxilizer appointed Christopher A. Thatcher as President and CEO, effective May 13, and he joined the board. He previously led Neuronetics through an IPO and holds senior roles at Integra and Bausch and Lomb. The company's NO2 sterilization process is awaiting final regulatory approval from two global biotech firms.NoxilizerHome -Noxilizer's proprietary Nitrogen Dioxide sterilization process is being utilized for ultra-low temperature sterilization of various medical products, including pre-filled syringes and orthopedic implants. Key findings show that this method ensures drug integrity and reduces sterilization costs and turnaround times, with several global biotech companies selecting Noxilizer for their sterilization needs, including evaluations for regulatory approval in 2023. The process aims to enhance supply chain efficiency and safety for medical device manufacturers.NordionSterigenics International and Noxilizer announce partnership to provide NO2 sterilization for pharmaceutical, biotech and medical device productsSterigenics International and Noxilizer have announced a partnership to provide nitrogen dioxide (NO2) sterilization services for pharmaceutical, biotech, and medical device products. This collaboration aims to expand sterilization options within the healthcare supply chain by leveraging Noxilizer's technology through Sterigenics' operational network. The move addresses growing industry demand for alternative sterilization methods that are effective yet less damaging to sensitive materials.PR NewswireSterigenics International et Noxilizer annoncent leur partenariat visant à offrir des services de stérilisation au dioxyde d'azote aux secteurs pharmaceutique, de la biotechnologie et de la fabricatioNoxilizer, Inc. and Sterigenics International LLC announced on October 3, 2017 a global partnership agreement making Sterigenics the exclusive worldwide provider of contract nitrogen dioxide (NO2) sterilization services, feasibility studies, and research for pharmaceutical, biotechnology, and medical device manufacturers. Noxilizer plans to deploy its first NO2 sterilization systems in select Sterigenics facilities in the United States and Europe before the end of 2017, with additional facilities to follow. The partnership provides clients with access to Sterigenics' integrated testing services through Nelson Laboratories, combining NO2 sterilization technology with full-service testing and consulting under one provider.Mpo-magSterigenics and Noxilizer Partner to Provide NO2 Sterilization for Medical ProductsNoxilizer Inc. and Sterigenics International LLC have signed a global agreement allowing Sterigenics to be the exclusive provider of nitrogen dioxide (NO2) contract sterilization services to the pharmaceutical, biotech, and medical device industries. This partnership aims to enhance NO2 sterilization capabilities with the first systems expected to be operational in select facilities in the United States and Europe by year’s end. The collaboration is designed to improve service offerings for customers seeking efficient sterilization solutions for medical products.